Human endogenous peptide p33 inhibits detrimental effects of LL-37 on osteoblast viability

Journal of Periodontal Research

Volumn 50, Issue 1, 2015, Pages 80-88

  Svensson, D ^a   Westman, J ^b   Wickstrom C ^c   Jonsson D ^a,c   Herwald, H ^b   Nilsson, B O ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c MALMÖ UNIVERSITY   (Sweden)

Author keywords

Antimicrobial peptide; Calcium; Cell number; Lactate dehydrogenase release

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; C1QBP PROTEIN, HUMAN; CALCIUM; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; CARRIER PROTEIN; COMPLEMENT 1Q RECEPTOR; COMPLEMENT COMPONENT C1Q; COMPLEMENT RECEPTOR; DNA; LACTATE DEHYDROGENASE; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; MUCIN;

ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL COUNT; CELL LINE; CELL MEMBRANE; CELL SHAPE; CELL SURVIVAL; DRUG EFFECTS; HUMAN; OSTEOBLAST;

ANTIMICROBIAL CATIONIC PEPTIDES; CALCIUM; CARRIER PROTEINS; CELL COUNT; CELL LINE; CELL MEMBRANE; CELL SHAPE; CELL SURVIVAL; COMPLEMENT C1Q; DNA; HUMANS; L-LACTATE DEHYDROGENASE; MEMBRANE GLYCOPROTEINS; MITOCHONDRIAL PROTEINS; MUCINS; OSTEOBLASTS; RECEPTORS, COMPLEMENT;

EID: 84920800294     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12184     Document Type: Article

References (26)

1. Burton MF, Steel PG. The chemistry and biology of LL-37. Nat Prod Rep 2009;26:1572-1584.
2. Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:1770-1773.
3. Zhang Z, Shively JE. Generation of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes. PLoS ONE 2010;5:e13985.
4. Vandamme D, Landuyt B, Luyten W, Schoofs L. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol 2012;280:22-35.
5. Chamorro CI, Weber G, Gronberg A, Pivarcsi A, Stahle M. The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes. J Invest Dermatol 2009;129:937-944.
6. Kim HJ, Cho DH, Lee KJ et al. LL-37 suppresses sodium nitroprusside-induced apoptosis of systemic sclerosis dermal fibroblasts. Exp Dermatol 2011;20:843-845.
7. Ciornei CD, Tapper H, Bjartell A, Sternby NH, Bodelsson M. Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study. BMC Cardiovasc Disord 2006;6:49.
8. Jönsson D, Nilsson BO. The antimicrobial peptide LL-37 is anti-inflammatory and proapoptotic in human periodontal ligament cells. J Periodont Res 2012;47:330-335.
9. Mader JS, Ewen C, Hancock RE, Bleackley RC. The human cathelicidin, LL-37, induces granzyme-mediated apoptosis in regulatory T cells. J Immunother 2011;34:229-235.
10. + -independent apoptosis. J Innate Immun 2013;5:290-300.
11. Lerner UH. Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res 2006;85:596-607.
12. Puklo M, Guentsch A, Hiemstra PS, Eick S, Potempa J. Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria. Oral Microbiol Immunol 2008;23:328-335.
13. Türkoglu O, Emingil G, Kutukculer N, Atilla G. Gingival crevicular fluid levels of cathelicidin LL-37 and interleukin-18 in patients with chronic periodontitis. J Periodontol 2009;80:969-976.
14. Herwald H, Dedio J, Kellner R, Loos M, Müller-Esterl W. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor. J Biol Chem 1996;271:13040-13047.
15. Peerschke EI, Murphy TK, Ghebrehiwet B. Activation-dependent surface expression of gC1qR/p33 on human platelets. Thromb Haemost 2003;89:331-339.
16. Ghebrehiwet B, Peerschke EI. Structure and function of gC1q-R: a multiligand binding cellular protein. Immunobiology 1998;199:225-238.
17. Westman J, Hansen FC, Olin AI, Mörgelin M, Schmidtchen A, Herwald H. p33 (gC1q receptor) prevents cell damage by blocking the cytolytic activity of antimicrobial peptides. J Immunol 2013;191:5714-5721.
18. Harris SA, Enger RJ, Riggs BL, Spelsberg TC. Development and characterization of conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 1995;10:178-186.
19. Bilbe G, Roberts E, Birch M, Evans DB. PCR phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell lines. Bone 1996;19:437-445.
20. Jönsson D, Wahlin Å, Idvall I, Johnsson I, Bratthall G, Nilsson BO. Differential effects of estrogen on DNA synthesis in human periodontal ligament and breast cancer cells. J Periodont Res 2005;40:401-406.
21. Nagant C, Pitts B, Nazmi K et al. Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Psedomonas aeruginosa using a library of truncated fragments. Antimicrob Agents Chemother 2012;56:5698-5708.
22. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
23. Bucki R, Namiot DB, Namiot Z, Savage PB, Janmey PA. Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13. J Antimicrob Chemother 2008;62:329-335.
24. Bals R, Wilson JM. Cathelicidins-a family of multifunctional antimicrobial peptides. Cell Mol Life Sci 2003;60:711-720.
25. Türkoglu O, Kandiloglu G, Berdeli A, Emingil G, Atilla G. Antimicrobial peptide hCAP-18/LL-37 protein and mRNA expressions in different periodontal diseases. Oral Dis 2011;17:60-67.
26. Sánchez GA, Miozza V, Delgado A, Busch L. Determination of salivary levels of mucin and amylase in chronic periodontitis patients. J Periodont Res 2011;46:221-227.